Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun;70(6):e30321.
doi: 10.1002/pbc.30321. Epub 2023 Apr 10.

Revaccination of children with acute lymphoblastic leukemia following completion of chemotherapy

Adi Anafy  1 , Gil Gilad  2 , Nadav Michaan  3 , Ronit Elhasid  4 , Hila Rosenfeld-Kaidar  4 , Nira Arad-Cohen  5 , Moran Szwarcwort Cohen  6 , Yael Shachor-Meyouhas  7 , Galia Grisaru-Soen  8
Affiliations

Revaccination of children with acute lymphoblastic leukemia following completion of chemotherapy

Adi Anafy et al. Pediatr Blood Cancer. 2023 Jun.

Abstract

Background: Intensive chemotherapy for acute lymphoblastic leukemia (ALL) may affect the immune system and potentially the immune memory causing antibodies provided by vaccination to disappear. There are disagreements regarding the guidelines for posttreatment immunization strategy.

Methods: Ninety-six children (aged 1-18 years at diagnosis) who completed chemotherapy for ALL were recruited. Antibody levels in the patient's serum against measles, varicella, polio, pertussis, hepatitis A, and hepatitis B were tested after completion of chemotherapy in patients who were fully vaccinated against these agents. Children who did not have positive serology to specific agents were revaccinated with a single dose accordingly. Antibody concentrations were measured again at least 4 weeks after revaccination.

Results: Positive antibody levels varied between the different agents. The highest percentage of positive serology was against polio (87%) and the lowest against pertussis (4%) (p < .001). There were significant differences between patients with high risk (HR) and non-HR ALL regarding serology status for some vaccines. After revaccination, the levels of response to each booster dose were significantly different: 100% after booster dose for varicella and polio, and only 34% after pertussis booster.

Conclusions: Loss of humoral protection for vaccine preventable diseases is a common finding among patients with ALL. Revaccination with one dose of vaccine after completion of chemotherapy achieved seroconversion in 34-100% of the patients depending on the type of vaccine. We recommend this revaccination schedule to all children who completed ALL therapy and were previously fully vaccinated.

Keywords: humoral immunity; leukemia; pediatrics; vaccination.

PubMed Disclaimer

References

REFERENCES

    1. Patel SR, Ortín M, Cohen BJ, et al. Revaccination of children after completion of standard chemotherapy for acute leukemia. Clin Infect Dis. 2007;44(5):635-642.
    1. Toret E, Yel SE, Suman M. Yeter Duzenli Kar, Zeynep Canan Ozdemir, Meltem Dinleyici & Ozcan Bor: immunization status and re-immunization of childhood acute lymphoblastic leukemia survivors. Hum Vaccin Immunother. 2021;17(4):1132-1135.
    1. Crawford NW, Heath JA, Ashley D, Downie P, P Buttery J. Survivors of childhood cancer: an Australian audit of vaccination status after treatment. Pediatr Blood Cancer. 2010;54(1):128-133.
    1. Rubin LG, Levin MJ, Ljungman P, et al. Infectious Diseases Society of America. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):309-318.
    1. Royal College of Paediatrics and Child Health (RCPCH). Immunisation of the immunocompromised child-Best practice statement. 2002.

LinkOut - more resources